Please use this identifier to cite or link to this item: http://repository.futminna.edu.ng:8080/jspui/handle/123456789/16882
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOjo, P.O.-
dc.contributor.authorBabayi, H.-
dc.contributor.authorOlayemi, I.K.-
dc.contributor.authorOladosun, O.P.-
dc.contributor.authorFadipe, L.A-
dc.contributor.authorBaba, E.-
dc.contributor.authorIzebe, K.-
dc.date.accessioned2023-01-07T15:36:57Z-
dc.date.available2023-01-07T15:36:57Z-
dc.date.issued2018-03-06-
dc.identifier.citation1-9en_US
dc.identifier.issn2329-843X-
dc.identifier.urihttp://repository.futminna.edu.ng:8080/jspui/handle/123456789/16882-
dc.description.abstractLeech salivary extract (LSE) was screened for the anti-tubercular activity against Mycobacterium tuberculosis using microbroth dilution method. The bioactive components in LSE were determined using Shimadzu GC-MS QP2010 SE. The LSE exhibited bactericidal effects on M. tuberculosis at 50% (v/v). The result of the GC-MS analysis of LSE revealed seventeen (17) bioactive components. The major fatty acid components were oleic acid (33.9%) and palmitic acid also known as hexadecanoic acid (22.6%). Other bioactive components detected in appreciable amounts in LSE include, 4-bromobutyric acid (16.86%), 6,17-Octadiene-1-ol acetate (9.78%) and octahydro-1,4,9,9- tetramethyl (5.21%). The anti-tubercular activity of the LSE was attributed to these bioactive components. The results obtained suggest that leech salivary extract could be used in treating tuberculosis.en_US
dc.language.isoenen_US
dc.publisherJournal of Tuberculosis Researchen_US
dc.relation.ispartofseriesVol. 4;no. 2-
dc.subjectGC-MS, Mycobacterium tuberculosis, Leech Salivary Extracten_US
dc.titleAnti-Tubercular Activities and Molecular Characterization of Salivary Extract of Leech (Hirudo medicinalis) against Mycobacterium tuberculosisen_US
dc.typeArticleen_US
Appears in Collections:Microbiology



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.